Michael W. Dunne
CIK 1553593 · Chief Scientific Officer · last filed 2025-11-20
Michael W. Dunne is a Chief Scientific Officer who has filed 36 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing shows the insider bought $2.2K of ITRM on Nov 20, 2025. Across all open-market trades the lifetime net is +$113.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
36
$113.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | Director | 241,001 | $0.03 | $7.2K | $113.0K | 30 | 2025-11-20 |
| AVIR | Director | — | $4.49 | — | $0 | 2 | 2017-05-22 |
| Vaxart, Inc. (BOTA) Delisted | Director | — | — | — | $0 | 1 | 2015-10-21 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Chief Medical Officer | 0 | — | — | $0 | 3 | 2014-11-18 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-20 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +6,000 | $2.2K | EDGAR |
| 2025-08-12 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +15,000 | $10.9K | EDGAR |
| 2024-08-12 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +106,247 | $0 | EDGAR |
| 2023-12-27 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +25,000 | $35.0K | EDGAR |
| 2023-12-19 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +10,000 | $18.4K | EDGAR |
| 2023-11-27 | Iterum Therapeutics plc (ITRM) Delisted | Buy (P) | +20,000 | $40.7K | EDGAR |
| 2023-10-02 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +3,487 | $0 | EDGAR |
| 2023-07-03 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +1,779 | $0 | EDGAR |
| 2023-06-15 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +15,853 | $0 | EDGAR |
| 2023-06-05 | Iterum Therapeutics plc (ITRM) Delisted | Exer (M) | +1,299 | $0 | EDGAR |